Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 1Motor Activity 1Digestive System Neoplasms 1Cachexia 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Body Height × Clear all
NCT02494869 2025-08-27

Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
75 enrolled

Motor Activity

NCT03172403 2022-08-25

MYOCAC

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Terminated
3 enrolled
Gastrointestinal

Cachexia, Digestive System Neoplasms

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Clinical Research Support Center Kyush

Phase 2 Unknown
110 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡